Stopped: Temporarily Closed
This early phase I trial tests the safety and reliability of an investigational imaging technique called quantitative oblique back illumination microscopy (qOBM) during brain surgery for detecting brain tumors and brain tumor margins in patients with glioblastoma, astrocytoma, or oligodendroglioma. Surgical margins refer to the edge or border of the tissue removed in cancer surgery. qOBM may be able to assess and reveal brain tumor surgical margins in a more safe and reliable manner.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Incidence of Adverse Events
Timeframe: Up to 3 years
Reliability of Quantitative Oblique Back Illumination Microscopy Device Determined by Frequency Distribution
Timeframe: Up to 3 years
Reliability of Quantitative Oblique Back Illumination Microscopy Device Determined by Standard Deviation
Timeframe: Up to 3 years
Reliability of Quantitative Oblique Back Illumination Microscopy Device Determined by Central Tendency
Timeframe: Up to 3 years
Reliability of Quantitative Oblique Back Illumination Microscopy Device Determined by Measures of Position
Timeframe: Up to 3 years